Metabolic activation of a pyrazinone-containing thrombin inhibitor. Evidence for novel biotransformation involving pyrazinone ring oxidation, rearrangement, and covalent binding to proteins.

Source:http://linkedlifedata.com/resource/pubmed/id/12588191

Download in:

View as

General Info

PMID
12588191